3Ikai I, Yamaoka Y, Yamamoto Y, et al . Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymphnode metastasis: proposal as a standard therapy[J]. Ann Surg, 1998,227(3) :443-449.
2Sinicrope FA,Rusan SB,Cleary KR. Bcl-2 and P53 oncoprotein expression during colorectal tumorrigenesis[J].Cancer Research,1995,(03):237-241.
3Sjostrom J,Blomqvist C,von Boguslawski K. The predictive value of bcl-2,bax,bcl-xL,bag-1,fas,and fas-L,for chemotherapy response in advanced breast cancer[J].Clinical Cancer Research,2002,(03):811.
4Cutress RI,Townsend PA,Brimmell M. BAG-1 expression and function in human cancer[J].British Journal of Cancer,2002,(08):834.
5Sauter ER,Nesbit M,Waston JC. Vascular endothelial growth factor is marker of tumor invasion and metastasis in squamous cell carcinoma of the head and neck[J].Clinical Cancer Research,1999,(04):775.
6An FQ,Matsude M,Fujii H. Expression of vascular endothelial growth factor in surgical speciman of hepatocellular carcinoma[J].Journal of Cancer Research and Clinical Oncology,2000,(03):153-160.doi:10.1007/s004320050025.
7Gustafsson AB,Gottlieb RA. Bcl-2 family members and apoptosis taken to heart[J].American Journal of Physiology-Cell Physiology,2007,(01):C45-C51.
8Tsamandas AC,Kardamakis D,Tsiamalos P. The potiential role of Bcl-2 expression,apoptosis and cell proliferation(Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome[J].Anticancer Research,2009,(02):703-709.
